⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2561862 | 0.89 | SIGMAR1 (0.46) | — | |
| SCHEMBL3244591 | 0.88 | — | — | |
| SCHEMBL678885 | 0.88 | — | — | |
| SCHEMBL3955804 | 0.87 | ALDH1A1 (0.43) | — | |
| SCHEMBL2552869 | 0.87 | ALDH1A1 (0.38) | — | |
| SCHEMBL3950976 | 0.87 | ALDH1A1 (0.46) | — | |
| Hydrochloric Acid SCHEMBL5552777 | 0.86 | HRH3 (0.42) | — | |
| SCHEMBL947690 | 0.86 | HRH3 (0.48) | — | |
| SCHEMBL29956822 | 0.86 | HRH3 (0.48) | — | |
| SCHEMBL5807819 | 0.86 | HRH3 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250127168-A1 | METHOD FOR PATHOGENS, MICROORGANISMS, AND PARASITES INACTIVATION | NEW YORK BLOOD CENTER, INC. | 2025-04-24 | — | — | US | disclosed |
| US-20250049031-A1 | METHOD FOR PATHOGENS, MICROORGANISMS, AND PARASITES INACTIVATION | NEW YORK BLOOD CENTER, INC. | 2025-02-13 | — | — | US | disclosed |
| US-20210227827-A1 | METHOD FOR PATHOGENS, MICROORGANISMS, AND PARASITES INACTIVATION | NEW YORK BLOOD CENTER, INC. | 2021-07-29 | — | — | US | disclosed |
| CN-112996545-A | Methods for pathogen, microbial and parasitic inactivation | 萨塔制药公司 | 2021-06-18 | — | — | CN | disclosed |
| EP-3829656-A1 | METHOD FOR PATHOGENS, MICROORGANISMS, AND PARASITES INACTIVATION | Zata Pharmaceuticals Inc. (US) | 2021-06-09 | — | — | EP | disclosed |
| US-10738005-B2 | Aziridinyl containing compounds and methods of inactivating nucleic acid molecules using the same | ZATA PHARMACEUTICALS, INC. (US) | 2020-08-11 | — | — | US | disclosed |
| US-10738005-B2 | Aziridinyl containing compounds and methods of inactivating nucleic acid molecules using the same | ZATA PHARMACEUTICALS, INC. (US) | 2020-08-11 | — | — | US | disclosed |
| WO-2020023881-A1 | METHOD FOR PATHOGENS, MICROORGANISMS, AND PARASITES INACTIVATION | ZATA PHARMACEUTICALS, INC. (US) | 2020-01-30 | — | — | WO | disclosed |
| US-20190106386-A1 | AZIRIDINYL CONTAINING COMPOUNDS AND METHODS OF INACTIVATING NUCLEIC ACID MOLECULES USING THE SAME | NEW YORK BLOOD CENTER, INC. | 2019-04-11 | — | — | US | disclosed |
| US-20190106386-A1 | AZIRIDINYL CONTAINING COMPOUNDS AND METHODS OF INACTIVATING NUCLEIC ACID MOLECULES USING THE SAME | NEW YORK BLOOD CENTER, INC. | 2019-04-11 | — | — | US | disclosed |
| US-20160289182-A1 | AZIRIDINYL CONTAINING COMPOUNDS AND METHODS OF INACTIVATING NUCLEIC ACID MOLECULES USING THE SAME | NEW YORK BLOOD CENTER, INC. | 2016-10-06 | — | — | US | disclosed |
| WO-2015073622-A1 | AZIRIDINYL CONTAINING COMPOUNDS AND METHODS OF INACTIVATING NUCLEIC ACID MOLECULES COMPRISING THE SAME | ZATA PHARMACEUTICALS, INC. (US) | 2015-05-21 | — | — | WO | disclosed |
| EP-1867633-A1 | Polyamine analogues as therapeutic and diagnostic agents | MediQuest Therapeutics, Inc. (US) | 2007-12-19 | — | — | EP | disclosed |
| US-7208528-B1 | Polyamine analogues as therapeutic and diagnostic agents | MEDIQUEST THERAPEUTICS, INC. (US) | 2007-04-24 | — | — | US | disclosed |
| US-7160923-B1 | Polyamine analogues as therapeutic and diagnostic agents | MEDIQUEST THERAPEUTICS, INC. (US) | 2007-01-09 | — | — | US | disclosed |
| EP-1085011-A1 | Novel polyamine analogues as therapeutic and diagnostic agents | ORIDIGM CORPORATION (US) | 2001-03-21 | — | — | EP | disclosed |
| US-6172261-B1 | BIOSYNTHESIS USING CHAIN EXTENSION | ORIDIGM CORPORATION | 2001-01-09 | — | — | US | disclosed |
| EP-1001927-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999003823-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 1999-01-28 | — | — | WO | disclosed |
| US-5612329-A | INTERFERENCE WITH CELL GROWTH AND PROLIFERATION | UNIVERSITY OF MARYLAND AT BALTIMORE (US) | 1997-03-18 | — | — | US | disclosed |